Small cell lung cancer (SCLC) accounts for 15% of all lung cancers and remains an aggressive disease with median survival…
Announced first patient dosed in the Phase 2b placebo-controlled portion of the EP-104GI RESOLVE trial with topline data expected in…
MUMBAI, India, June 2, 2025 /PRNewswire/ -- Infigrowth, the digital growth platform developed by Infidigit, India's leading SEO agency, has introduced…